Suchergebnisse - "De Giorgi, Ugo"

PubPharm (5)

1

Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes : A Systematic Review and Safety Meta-analysis

enthalten in: Targeted oncology | 2024

von Maiorano, B. | De Giorgi, U. | Verzoni, E. | +5

ErratumIn: Target Oncol. 2023 Dec 9;:. - PMID 38070004

2

Correction to : Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis

enthalten in: Targeted oncology | 2024

von Maiorano, B. | De Giorgi, U. | Verzoni, E. | +5

ErratumFor: Target Oncol. 2024 Jan;19(1):1-11. - PMID 37993604

3

Vitamin D Deficiency in Testicular Cancer Survivors : A Systematic Review

enthalten in: International journal of molecular sciences | 2021

von Schepisi, G. | Gianni, C. | Bleve, S. | +10

4

Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors : a systematic review and meta-analysis of clinical trials

enthalten in: International journal of cancer | 2014

von Santoni, M. | Conti, A. | De Giorgi, U. | +7

5

Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta‐analysis of clinical trials

enthalten in: International journal of cancer | 2014

von Santoni, M. | Conti, A. | De Giorgi, U. | +7

1
[1]